Security key
60770K107
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 262,225,074
- Total 13F value
- $27,942,962,472
- Share change
- +5,948,664
- Put/Call ratio
- 77%
- SEC-reported price per share
- $106.56
- Number of holders
- 887
- Value change
- +$671,576,108
- Number of buys
- 419
- Number of sells
- 369
- Shares outstanding
- 398,175,325
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
887
Top holders
10
MRNA full security history
Ownership snapshot
Full 13F holder table
Moderna, Inc. SEC filings
Moderna, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MRNA - Moderna, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BAILLIE GIFFORD & CO
Disclosed value leader
BAILLIE GIFFORD & CO
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F
Highest disclosed value: $4,540,342,711
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BAILLIE GIFFORD & CO has the largest disclosed position value at $4.54B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BAILLIE GIFFORD & CO's linked filing trail.
Disclosed position value
Top 5
BAILLIE GIFFORD & CO
$4.54B
VANGUARD GROUP INC
$3.37B
BlackRock Finance, Inc.
$2.52B
STATE STREET CORP
$1.45B
Flagship Pioneering, LLC
$961.29M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO |
13F
Company
|
—
denominator unverified
|
$4,540,342,711
45,654,527 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$3,372,058,312
33,907,072 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$2,516,253,271
25,301,692 shares
|
— | 31 Dec 2023 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$1,454,329,252
14,623,723 shares
|
— | 31 Dec 2023 |
| Flagship Pioneering, LLC |
13F
Company
|
—
denominator unverified
|
$961,287,479
9,666,038 shares
|
— | 31 Dec 2023 |
| Theleme Partners LLP |
13F
Company
|
—
denominator unverified
|
$730,903,399
7,349,456 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
887
Shares
262,225,074
Rows available
887
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
887
Q1 2024 holders
887
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|